Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

Indiana's workforce is feeling pressure to return to the office, but a good portion of employees still like hybrid work. Is ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

including the merger of its pharmaceuticals and oncology businesses into a single unit with separate US and international commercial operations, and a cost-cutting drive that aims to save $1.5 ...

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical ... by Eli Lilly in 1982 as Humulin.

LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the ...

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, banking on the launch of its popular ...

Eli Lilly’s latest TV ad, unveiled during the Grammys on Sunday night, highlights the importance of early diagnosis for ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

A woman's hands star in a Lilly spot, shown playing key role in activities like gardening -- and discovering a lump in her ...